ACTNOW Opens the Gate for Timely, Novel Research - August 11, 2009
NCI announces a new program being supported by Recovery Act funding. The Accelerating Clinical Trials of Novel Oncologic Pathways (ACTNOW) program will advance targeted, personalized cancer treatment through 37 early-phase clinical trials of new cancer therapies.
Read the story in the NCI Cancer Bulletin

Recovery Act Boosts Informatics - May 5, 2009
Top federal health information technology officials are predicting that the Recovery Act will help push development and adoption of health IT and interconnectivity to dramatically new levels over the coming years.
Read the story in the NCI Cancer Bulletin

Recovery Act Impact - April 20, 2009
NCI Director John E. Niederhuber, M.D., discusses the impact of the Recovery Act on cancer research at the Annual Meeting of the American Association for Cancer Research:
Press Release | Webcast | Text